{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:57:18Z","timestamp":1795107438104,"version":"4.10.3"},"reference-count":168,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:title>Abstract:<\/jats:title><jats:p>Diabetes is a major risk factor for the development of heart failure. One of the hallmarks of diabetes is insulin resistance associated with hyperinsulinemia. The literature shows that insulin and adrenergic signaling is intimately linked to each other; however, whether and how insulin may modulate cardiac adrenergic signaling and cardiac function remains unknown. Notably, recent studies have revealed that insulin receptor and \u03b2<jats:sub>2<\/jats:sub>adrenergic receptor (\u03b2<jats:sub>2<\/jats:sub>AR) forms a membrane complex in animal hearts, bringing together the direct contact between 2 receptor signaling systems, and forming an integrated and dynamic network. Moreover, insulin can drive cardiac adrenergic desensitization via protein kinase A and G protein-receptor kinases phosphorylation of the \u03b2<jats:sub>2<\/jats:sub>AR, which compromises adrenergic regulation of cardiac contractile function. In this review, we will explore the current state of knowledge linking insulin and G protein\u2013coupled receptor signaling, especially \u03b2-adrenergic receptor signaling in the heart, with emphasis on molecular insights regarding its role in diabetic cardiomyopathy.<\/jats:p>","DOI":"10.1097\/fjc.0000000000000481","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T03:57:53Z","timestamp":1490155073000},"page":"74-86","source":"Crossref","is-referenced-by-count":27,"title":["Cross-Talk Between Insulin Signaling and G Protein\u2013Coupled Receptors"],"prefix":"10.1097","volume":"70","author":[{"given":"Qin","family":"Fu","sequence":"first","affiliation":[{"name":"Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China;"},{"name":"The Key Laboratory for Drug Target Research and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of California at Davis, Davis, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni M.","family":"West","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of California at Davis, Davis, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang K.","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of California at Davis, Davis, CA;"},{"name":"VA Northern California Healthcare System, Mather, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230911","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1161\/CIRCULATIONAHA.107.188965","article-title":"Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group","volume":"117","author":"Schocken","year":"2008","journal-title":"Circulation"},{"key":"R2-20230911","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am J Cardiol."},{"key":"R3-20230911","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.amjmed.2006.05.024","article-title":"Diabetes in heart failure: prevalence and impact on outcome in the population","volume":"119","author":"From","year":"2006","journal-title":"Am J Med."},{"key":"R4-20230911","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0002-9149(97)89163-1","article-title":"Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry","volume":"77","author":"Shindler","year":"1996","journal-title":"Am J Cardiol."},{"key":"R5-20230911","doi-asserted-by":"crossref","first-page":"e60931","DOI":"10.1371\/journal.pone.0060931","article-title":"Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy","volume":"8","author":"Calligaris","year":"2013","journal-title":"PLoS One"},{"key":"R6-20230911","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2015.06.136","article-title":"A high-sugar and high-fat diet impairs cardiac systolic and diastolic function in mice","volume":"198","author":"Carbone","year":"2015","journal-title":"Int J Cardiol."},{"key":"R7-20230911","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/j.ddmec.2010.08.001","article-title":"Diabetic cardiomyopathy: mechanisms and therapeutic targets","volume":"7","author":"Battiprolu","year":"2010","journal-title":"Drug Discov Today Dis Mech."},{"key":"R8-20230911","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009191","article-title":"Insulin receptor signaling in normal and insulin-resistant states","volume":"6","author":"Boucher","year":"2014","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"R9-20230911","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0008-6363(97)00051-5","article-title":"Actions of insulin on the mammalian heart: metabolism, pathology and biochemical mechanisms","volume":"34","author":"Brownsey","year":"1997","journal-title":"Cardiovasc Res."},{"key":"R10-20230911","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/CIRCRESAHA.116.306206","article-title":"Insulin signaling and heart failure","volume":"118","author":"Riehle","year":"2016","journal-title":"Circ Res."},{"key":"R11-20230911","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1172\/JCI114487","article-title":"Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet","volume":"85","author":"Feldman","year":"1990","journal-title":"J Clin Invest."},{"key":"R12-20230911","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJM198207223070401","article-title":"Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts","volume":"307","author":"Bristow","year":"1982","journal-title":"New Engl J Med."},{"key":"R13-20230911","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.CIR.87.2.454","article-title":"Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart","volume":"87","author":"Ungerer","year":"1993","journal-title":"Circulation"},{"key":"R14-20230911","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00227878","article-title":"Regulation of G protein function: implications for heart disease","volume":"157","author":"Meij","year":"1996","journal-title":"Mol Cell Biochem."},{"key":"R15-20230911","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1074\/jbc.271.2.1061","article-title":"The beta-adrenergic receptor is a substrate for the insulin receptor tyrosine kinase","volume":"271","author":"Baltensperger","year":"1996","journal-title":"J Biol Chem."},{"key":"R16-20230911","doi-asserted-by":"crossref","first-page":"24805","DOI":"10.1016\/S0021-9258(17)31463-1","article-title":"Endothelin induces tyrosine phosphorylation and GRB2 association of Shc in astrocytes","volume":"269","author":"Cazaubon","year":"1994","journal-title":"J Biol Chem."},{"key":"R17-20230911","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/j.1460-2075.1996.tb00441.x","article-title":"Shc adaptor proteins are key transducers of mitogenic signaling mediated by the G protein-coupled thrombin receptor","volume":"15","author":"Chen","year":"1996","journal-title":"EMBO J."},{"key":"R18-20230911","doi-asserted-by":"crossref","first-page":"29347","DOI":"10.1074\/jbc.271.46.29347","article-title":"Insulin-like growth factor receptor-1 stimulates phosphorylation of the beta2-adrenergic receptor in vivo on sites distinct from those phosphorylated in response to insulin","volume":"271","author":"Karoor","year":"1996","journal-title":"J Biol Chem."},{"key":"R19-20230911","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S1357-2725(02)00300-X","article-title":"Angiotensin II signaling pathways mediated by tyrosine kinases","volume":"35","author":"Yin","year":"2003","journal-title":"Int J Biochem Cell Biol."},{"issue":"pt 2","key":"R20-20230911","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/bj3500413","article-title":"Cross-talk between receptors with intrinsic tyrosine kinase activity and alpha1b-adrenoceptors","volume":"350","author":"del Carmen Medina","year":"2000","journal-title":"Biochem J."},{"key":"R21-20230911","first-page":"51","article-title":"Crosstalk coregulation mechanisms of G protein-coupled receptors and receptor tyrosine kinases","volume":"332","author":"Natarajan","year":"2006","journal-title":"Methods Mol Biol."},{"key":"R22-20230911","doi-asserted-by":"crossref","first-page":"R1532","DOI":"10.1152\/ajpregu.00076.2015","article-title":"Positive effect of combined exercise training in a model of metabolic syndrome and menopause: autonomic, inflammatory, and oxidative stress evaluations","volume":"309","author":"Conti","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"R23-20230911","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.CIR.98.22.2453","article-title":"Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms","volume":"98","author":"Nickenig","year":"1998","journal-title":"Circulation"},{"key":"R24-20230911","doi-asserted-by":"crossref","first-page":"26017","DOI":"10.1016\/S0021-9258(18)35710-7","article-title":"Cross-talk between tyrosine kinase and G-protein-linked receptors. Phosphorylation of beta 2-adrenergic receptors in response to insulin","volume":"267","author":"Hadcock","year":"1992","journal-title":"J Biol Chem."},{"key":"R25-20230911","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10495-007-0169-2","article-title":"Insulin inhibits beta-adrenergic action in ischemic\/reperfused heart: a novel mechanism of insulin in cardioprotection","volume":"13","author":"Yu","year":"2008","journal-title":"Apoptosis."},{"key":"R26-20230911","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.RES.0000150049.74539.8a","article-title":"Phosphatidylinositol 3-kinase offsets cAMP-mediated positive inotropic effect via inhibiting Ca2+ influx in cardiomyocytes","volume":"95","author":"Leblais","year":"2004","journal-title":"Circ Res."},{"key":"R27-20230911","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1161\/01.RES.0000024115.67561.54","article-title":"Phosphatidylinositol 3-kinase functionally compartmentalizes the concurrent G(s) signaling during beta2-adrenergic stimulation","volume":"91","author":"Jo","year":"2002","journal-title":"Circ Res."},{"key":"R28-20230911","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0306-3623(94)90214-3","article-title":"Increased alpha 1-adrenergic responsiveness of alloxan diabetic rat atria: effects of insulin therapy and thyroidectomy","volume":"25","author":"Lafci-Erol","year":"1994","journal-title":"Gen Pharmacol."},{"key":"R29-20230911","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.lfs.2004.03.025","article-title":"Insulin induces alpha1B-adrenergic receptor phosphorylation and desensitization","volume":"75","author":"Garcia-Sainz","year":"2004","journal-title":"Life Sci."},{"key":"R30-20230911","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1172\/JCI0213946","article-title":"Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression","volume":"109","author":"Belke","year":"2002","journal-title":"J Clin Invest."},{"key":"R31-20230911","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/MCB.01110-06","article-title":"Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function","volume":"27","author":"Laustsen","year":"2007","journal-title":"Mol Cell Biol."},{"key":"R32-20230911","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1126\/science.1079206","article-title":"Myocyte adrenoceptor signaling pathways","volume":"300","author":"Xiang","year":"2003","journal-title":"Science."},{"key":"R33-20230911","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.tips.2006.04.009","article-title":"Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart","volume":"27","author":"Xiao","year":"2006","journal-title":"Trends Pharmacol Sci."},{"key":"R34-20230911","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1006\/jmcc.2000.1270","article-title":"Phospholamban and cardiac contractile function","volume":"32","author":"Brittsan","year":"2000","journal-title":"J Mol Cell Cardiol."},{"key":"R35-20230911","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature04140","article-title":"Insulin disrupts beta-adrenergic signalling to protein kinase A in adipocytes","volume":"437","author":"Zhang","year":"2005","journal-title":"Nature"},{"key":"R36-20230911","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.2337\/db13-1763","article-title":"Insulin inhibits cardiac contractility by inducing a Gi-biased beta2-adrenergic signaling in hearts","volume":"63","author":"Fu","year":"2014","journal-title":"Diabetes"},{"key":"R37-20230911","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1050-1738(01)00145-1","article-title":"Dual site phospholamban phosphorylation and its physiological relevance in the heart","volume":"12","author":"Hagemann","year":"2002","journal-title":"Trends Cardiovasc Med."},{"key":"R38-20230911","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12471-014-0590-4","article-title":"Troponin I phosphorylation in human myocardium in health and disease","volume":"22","author":"Wijnker","year":"2014","journal-title":"Neth Heart J."},{"key":"R39-20230911","doi-asserted-by":"crossref","first-page":"16574","DOI":"10.1073\/pnas.0607294103","article-title":"Phosphorylation of serine 1928 in the distal C-terminal domain of cardiac CaV1.2 channels during beta1-adrenergic regulation","volume":"103","author":"Hulme","year":"2006","journal-title":"Proc Natl Acad Sci U S A."},{"key":"R40-20230911","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/HCO.0b013e3282294d72","article-title":"Reversal of cardiac remodeling by modulation of adrenergic receptors: a new frontier in heart failure","volume":"22","author":"Perrino","year":"2007","journal-title":"Curr Opin Cardiol."},{"key":"R41-20230911","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cellsig.2014.11.018","article-title":"Insulin induces IRS2-dependent and GRK2-mediated beta2AR internalization to attenuate betaAR signaling in cardiomyocytes","volume":"27","author":"Fu","year":"2015","journal-title":"Cell Signal."},{"key":"R42-20230911","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)80847-8","article-title":"PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts","volume":"101","author":"Marx","year":"2000","journal-title":"Cell"},{"key":"R43-20230911","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.yjmcc.2008.04.004","article-title":"Compartmentalisation of cAMP-dependent signalling by caveolae in the adult cardiac myocyte","volume":"45","author":"Calaghan","year":"2008","journal-title":"J Mol Cell Cardiol."},{"key":"R44-20230911","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/01.RES.84.1.43","article-title":"Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes","volume":"84","author":"Xiao","year":"1999","journal-title":"Circ Res."},{"key":"R45-20230911","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/CIRCRESAHA.108.187880","article-title":"Dynamic protein kinase a activities induced by beta-adrenoceptors dictate signaling propagation for substrate phosphorylation and myocyte contraction","volume":"104","author":"Soto","year":"2009","journal-title":"Circ Res."},{"key":"R46-20230911","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1073\/pnas.0405263102","article-title":"Phosphodiesterase 4D is required for beta2 adrenoceptor subtype-specific signaling in cardiac myocytes","volume":"102","author":"Xiang","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"key":"R47-20230911","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/01.RES.0000250046.69918.d5","article-title":"Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling","volume":"99","author":"Nikolaev","year":"2006","journal-title":"Circ Res."},{"key":"R48-20230911","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1172\/JCI118823","article-title":"Functional beta3-adrenoceptor in the human heart","volume":"98","author":"Gauthier","year":"1996","journal-title":"J Clin Invest."},{"key":"R49-20230911","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.phrs.2009.01.002","article-title":"The beta3-adrenoceptor as a therapeutic target: current perspectives","volume":"59","author":"Ursino","year":"2009","journal-title":"Pharmacol Res."},{"key":"R50-20230911","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1139\/y84-020","article-title":"Effect of experimental diabetes on isolated rat heart responsiveness to isoproterenol","volume":"62","author":"Vadlamudi","year":"1984","journal-title":"Can J Physiol Pharmacol."},{"key":"R51-20230911","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0022-3565(25)24674-2","article-title":"Altered inotropic responses in diabetic cardiomyopathy and hypertensive-diabetic cardiomyopathy","volume":"257","author":"Yu","year":"1991","journal-title":"J Pharmacol Exp Ther."},{"key":"R52-20230911","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0306-3623(93)90029-W","article-title":"The effects of glyburide and insulin on the cardiac performance in rats with non-insulin-dependent diabetes mellitus","volume":"24","author":"Ozuari","year":"1993","journal-title":"Gen Pharmacol."},{"key":"R53-20230911","doi-asserted-by":"crossref","first-page":"594213","DOI":"10.1155\/2013\/594213","article-title":"The functional state of hormone-sensitive adenylyl cyclase signaling system in diabetes mellitus","volume":"2013","author":"Shpakov","year":"2013","journal-title":"J Signal Transduct."},{"key":"R54-20230911","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2337\/diabetes.50.2.455","article-title":"The effect of diabetes on expression of beta1-, beta2-, and beta3-adrenoreceptors in rat hearts","volume":"50","author":"Dincer","year":"2001","journal-title":"Diabetes"},{"key":"R55-20230911","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0006-2952(99)00164-1","article-title":"Diabetes-induced down-regulation of beta1-adrenoceptor mRNA expression in rat heart","volume":"58","author":"Matsuda","year":"1999","journal-title":"Biochem Pharmacol."},{"key":"R56-20230911","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0022-3565(24)36768-0","article-title":"Impaired contractile response to beta adrenoceptor stimulation in diabetic rat hearts: alterations in beta adrenoceptors-G protein-adenylate cyclase system and phospholamban phosphorylation","volume":"282","author":"Gando","year":"1997","journal-title":"J Pharmacol Exp Ther."},{"key":"R57-20230911","first-page":"357","article-title":"Changes in cardiac contractility in IDDM and NIDDM diabetic rats","volume":"15","author":"Banyasz","year":"1996","journal-title":"Gen Physiol Biophys."},{"key":"R58-20230911","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM198406143102406","article-title":"Mechanisms of membrane-receptor regulation. Biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors","volume":"310","author":"Lefkowitz","year":"1984","journal-title":"New Engl J Med."},{"issue":"2 pt 1","key":"R59-20230911","first-page":"E127","article-title":"Plasma membrane-specific deficiency in cardiac beta-adrenergic receptor in streptozocin-diabetic rats","volume":"257","author":"Kashiwagi","year":"1989","journal-title":"Am J Physiol."},{"issue":"suppl 1","key":"R60-20230911","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1038\/sj.bjp.0707662","article-title":"G-protein-coupled receptor phosphorylation: where, when and by whom","volume":"153","author":"Tobin","year":"2008","journal-title":"Br J Pharmacol."},{"key":"R61-20230911","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1016\/S0021-9258(18)88892-5","article-title":"Phosphorylation of the mammalian beta-adrenergic receptor by cyclic AMP-dependent protein kinase. Regulation of the rate of receptor phosphorylation and dephosphorylation by agonist occupancy and effects on coupling of the receptor to the stimulatory guanine nucleotide regulatory protein","volume":"260","author":"Benovic","year":"1985","journal-title":"J Biol Chem."},{"key":"R62-20230911","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1073\/pnas.83.9.2797","article-title":"Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor","volume":"83","author":"Benovic","year":"1986","journal-title":"Proc Natl Acad Sci U S A."},{"key":"R63-20230911","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tips.2008.05.006","article-title":"Location, location, location\u2026site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling","volume":"29","author":"Tobin","year":"2008","journal-title":"Trends Pharmacol Sci."},{"key":"R64-20230911","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0163-7258(93)90030-H","article-title":"Beta-adrenoceptors in cardiac disease","volume":"60","author":"Brodde","year":"1993","journal-title":"Pharmacol Ther."},{"key":"R65-20230911","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0031-6997(25)06662-1","article-title":"Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure","volume":"43","author":"Brodde","year":"1991","journal-title":"Pharmacol Rev."},{"key":"R66-20230911","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/36362","article-title":"Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A","volume":"390","author":"Daaka","year":"1997","journal-title":"Nature"},{"key":"R67-20230911","doi-asserted-by":"crossref","first-page":"31249","DOI":"10.1074\/jbc.M202753200","article-title":"Protein kinase A-mediated phosphorylation of the beta 2-adrenergic receptor regulates its coupling to Gs and Gi. Demonstration in a reconstituted system","volume":"277","author":"Zamah","year":"2002","journal-title":"J Biol Chem."},{"key":"R68-20230911","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.cellsig.2004.05.002","article-title":"PKA-mediated phosphorylation of the beta1-adrenergic receptor promotes Gs\/Gi switching","volume":"16","author":"Martin","year":"2004","journal-title":"Cell Signal."},{"key":"R69-20230911","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0092-8674(91)90098-J","article-title":"ERKs: a family of protein-serine\/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF","volume":"65","author":"Boulton","year":"1991","journal-title":"Cell"},{"key":"R70-20230911","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/emboj\/18.4.893","article-title":"The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579","volume":"18","author":"Hoffmann","year":"1999","journal-title":"EMBO J."},{"key":"R71-20230911","doi-asserted-by":"crossref","first-page":"33824","DOI":"10.1074\/jbc.M109.020388","article-title":"Differential association of phosphodiesterase 4D isoforms with beta2-adrenoceptor in cardiac myocytes","volume":"284","author":"De Arcangelis","year":"2009","journal-title":"J Biol Chem."},{"key":"R72-20230911","doi-asserted-by":"crossref","first-page":"12657","DOI":"10.1016\/S0021-9258(18)63907-9","article-title":"Phosphorylation sites on two domains of the beta 2-adrenergic receptor are involved in distinct pathways of receptor desensitization","volume":"264","author":"Hausdorff","year":"1989","journal-title":"J Biol Chem."},{"key":"R73-20230911","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1124\/mol.58.5.1162","article-title":"Localization of the sites mediating desensitization of the beta(2)-adrenergic receptor by the GRK pathway","volume":"58","author":"Seibold","year":"2000","journal-title":"Mol Pharmacol."},{"key":"R74-20230911","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/mol.65.1.196","article-title":"Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies","volume":"65","author":"Tran","year":"2004","journal-title":"Mol Pharmacol."},{"key":"R75-20230911","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.2337\/db10-0771","article-title":"G protein-coupled receptor kinase 2 plays a relevant role in insulin resistance and obesity","volume":"59","author":"Garcia-Guerra","year":"2010","journal-title":"Diabetes"},{"key":"R76-20230911","doi-asserted-by":"crossref","first-page":"ra73","DOI":"10.1126\/scisignal.aaa4374","article-title":"Reversal of diet-induced obesity and insulin resistance by inducible genetic ablation of GRK2","volume":"8","author":"Vila-Bedmar","year":"2015","journal-title":"Sci Signal."},{"issue":"12 pt A","key":"R77-20230911","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/j.bbadis.2014.09.004","article-title":"Downregulation of G protein-coupled receptor kinase 2 levels enhances cardiac insulin sensitivity and switches on cardioprotective gene expression patterns","volume":"1842","author":"Lucas","year":"2014","journal-title":"Biochim Biophys Acta."},{"key":"R78-20230911","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1161\/CIRCRESAHA.114.300513","article-title":"G protein-coupled receptor kinase 2: a link between myocardial contractile function and cardiac metabolism","volume":"114","author":"Woodall","year":"2014","journal-title":"Circ Res."},{"key":"R79-20230911","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1161\/CIRCULATIONAHA.110.988642","article-title":"G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia","volume":"123","author":"Ciccarelli","year":"2011","journal-title":"Circulation"},{"key":"R80-20230911","doi-asserted-by":"crossref","first-page":"32279","DOI":"10.1074\/jbc.M109.021428","article-title":"Agonist dose-dependent phosphorylation by protein kinase A and G protein-coupled receptor kinase regulates beta2 adrenoceptor coupling to G(i) proteins in cardiomyocytes","volume":"284","author":"Liu","year":"2009","journal-title":"J Biol Chem."},{"key":"R81-20230911","doi-asserted-by":"crossref","first-page":"re15","DOI":"10.1126\/stke.2001.104.re15","article-title":"Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins","volume":"2001","author":"Xiao","year":"2001","journal-title":"Science STKE."},{"key":"R82-20230911","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2011.08.001","article-title":"G protein-coupled receptor kinases: more than just kinases and not only for GPCRs","volume":"133","author":"Gurevich","year":"2012","journal-title":"Pharmacol Ther."},{"key":"R83-20230911","doi-asserted-by":"crossref","first-page":"8558","DOI":"10.1016\/S0021-9258(18)42479-9","article-title":"Receptor-specific desensitization with purified proteins. Kinase dependence and receptor specificity of beta-arrestin and arrestin in the beta 2-adrenergic receptor and rhodopsin systems","volume":"267","author":"Lohse","year":"1992","journal-title":"J Biol Chem."},{"key":"R84-20230911","doi-asserted-by":"crossref","first-page":"18677","DOI":"10.1074\/jbc.273.30.18677","article-title":"G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization","volume":"273","author":"Lefkowitz","year":"1998","journal-title":"J Biol Chem."},{"key":"R85-20230911","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1073\/pnas.88.14.6201","article-title":"Comparative rates of desensitization of beta-adrenergic receptors by the beta-adrenergic receptor kinase and the cyclic AMP-dependent protein kinase","volume":"88","author":"Roth","year":"1991","journal-title":"Proc Natl Acad Sci U S A."},{"key":"R86-20230911","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/327229a0","article-title":"Abolition of the expression of inhibitory guanine nucleotide regulatory protein Gi activity in diabetes","volume":"327","author":"Gawler","year":"1987","journal-title":"Nature"},{"key":"R87-20230911","doi-asserted-by":"crossref","first-page":"13240","DOI":"10.1074\/jbc.M011578200","article-title":"c-Src tyrosine kinase binds the beta 2-adrenergic receptor via phospho-Tyr-350, phosphorylates G-protein-linked receptor kinase 2, and mediates agonist-induced receptor desensitization","volume":"276","author":"Fan","year":"2001","journal-title":"J Biol Chem."},{"key":"R88-20230911","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/bbrc.1994.1443","article-title":"The angiotensin II AT1 receptor is tyrosine and serine phosphorylated and can serve as a substrate for the src family of tyrosine kinases","volume":"200","author":"Paxton","year":"1994","journal-title":"Biochem Biophys Res Commun."},{"key":"R89-20230911","doi-asserted-by":"crossref","first-page":"33035","DOI":"10.1074\/jbc.273.49.33035","article-title":"Insulin stimulates sequestration of beta-adrenergic receptors and enhanced association of beta-adrenergic receptors with Grb2 via tyrosine 350","volume":"273","author":"Karoor","year":"1998","journal-title":"J Biol Chem."},{"key":"R90-20230911","doi-asserted-by":"crossref","first-page":"25305","DOI":"10.1074\/jbc.270.43.25305","article-title":"Phosphorylation of tyrosyl residues 350\/354 of the beta-adrenergic receptor is obligatory for counterregulatory effects of insulin","volume":"270","author":"Karoor","year":"1995","journal-title":"J Biol Chem."},{"key":"R91-20230911","doi-asserted-by":"crossref","first-page":"15124","DOI":"10.1074\/jbc.M108771200","article-title":"Akt mediates sequestration of the beta(2)-adrenergic receptor in response to insulin","volume":"277","author":"Doronin","year":"2002","journal-title":"J Biol Chem."},{"key":"R92-20230911","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.pharmthera.2005.09.008","article-title":"The structural basis of arrestin-mediated regulation of G-protein-coupled receptors","volume":"110","author":"Gurevich","year":"2006","journal-title":"Pharmacol Ther."},{"key":"R93-20230911","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0898-6568(97)00195-2","article-title":"Serum and insulin induce a Grb2-dependent shift in agonist affinity of beta-adrenergic receptors","volume":"10","author":"Shih","year":"1998","journal-title":"Cell Signal."},{"key":"R94-20230911","doi-asserted-by":"crossref","first-page":"36086","DOI":"10.1074\/jbc.M004404200","article-title":"Insulin activation of mitogen-activated protein kinases Erk1,2 is amplified via beta-adrenergic receptor expression and requires the integrity of the Tyr350 of the receptor","volume":"275","author":"Wang","year":"2000","journal-title":"J Biol Chem."},{"key":"R95-20230911","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tem.2006.01.006","article-title":"G-protein-coupled receptors and tyrosine kinases: crossroads in cell signaling and regulation","volume":"17","author":"Gavi","year":"2006","journal-title":"Trends Endocrinol Metab."},{"key":"R96-20230911","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1152\/physrev.1999.79.4.1373","article-title":"Physiological regulation of G protein-linked signaling","volume":"79","author":"Morris","year":"1999","journal-title":"Physiol Rev."},{"key":"R97-20230911","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.2042-7158.1994.tb03806.x","article-title":"The in-vitro effects of insulin and the effects of acute fasting on cardiac beta-adrenoceptor responses in the short-term streptozotocin-diabetic rat","volume":"46","author":"Austin","year":"1994","journal-title":"J Pharm Pharmacol."},{"key":"R98-20230911","doi-asserted-by":"crossref","first-page":"15553","DOI":"10.1016\/S0021-9258(19)37624-0","article-title":"Effects of insulin on adrenoceptor binding and the rate of catecholamine-induced lipolysis in isolated human fat cells","volume":"263","author":"Engfeldt","year":"1988","journal-title":"J Biol Chem."},{"key":"R99-20230911","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.1128\/MCB.22.17.6272-6285.2002","article-title":"Insulin induces heterologous desensitization of G-protein-coupled receptor and insulin-like growth factor I signaling by downregulating beta-arrestin-1","volume":"22","author":"Dalle","year":"2002","journal-title":"Mol Cell Biol."},{"key":"R100-20230911","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1472-8206.1995.tb00279.x","article-title":"Reduced beta-adrenergic sensitivity in healthy volunteers induced by hypoglycemia","volume":"9","author":"Trovik","year":"1995","journal-title":"Fundam Clin Pharmacol."},{"key":"R101-20230911","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1083\/jcb.200202113","article-title":"Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor\/beta-arrestin complex","volume":"158","author":"Naga Prasad","year":"2002","journal-title":"J Cell Biol."},{"key":"R102-20230911","doi-asserted-by":"crossref","first-page":"18302","DOI":"10.1074\/jbc.271.31.18302","article-title":"Dynamin and beta-arrestin reveal distinct mechanisms for G protein-coupled receptor internalization","volume":"271","author":"Zhang","year":"1996","journal-title":"J Biol Chem."},{"key":"R103-20230911","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ncb1278","article-title":"Protein kinase activity of phosphoinositide 3-kinase regulates beta-adrenergic receptor endocytosis","volume":"7","author":"Naga Prasad","year":"2005","journal-title":"Nat Cell Biol."},{"key":"R104-20230911","doi-asserted-by":"crossref","first-page":"9773","DOI":"10.1074\/jbc.M511435200","article-title":"Agonist-stimulated beta-adrenergic receptor internalization requires dynamic cytoskeletal actin turnover","volume":"281","author":"Volovyk","year":"2006","journal-title":"J Biol Chem."},{"key":"R105-20230911","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1093\/emboj\/cdg628","article-title":"Protein kinase A regulates AKAP250 (gravin) scaffold binding to the beta2-adrenergic receptor","volume":"22","author":"Tao","year":"2003","journal-title":"EMBO J."},{"key":"R106-20230911","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1074\/jbc.274.3.1185","article-title":"Src-mediated tyrosine phosphorylation of dynamin is required for beta2-adrenergic receptor internalization and mitogen-activated protein kinase signaling","volume":"274","author":"Ahn","year":"1999","journal-title":"J Biol Chem."},{"key":"R107-20230911","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1091\/mbc.e02-03-0174","article-title":"pp60Src mediates insulin-stimulated sequestration of the beta(2)-adrenergic receptor: insulin stimulates pp60Src phosphorylation and activation","volume":"13","author":"Shumay","year":"2002","journal-title":"Mol Biol Cel."},{"issue":"pt 4","key":"R108-20230911","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1242\/jcs.00890","article-title":"Trafficking of beta2-adrenergic receptors: insulin and beta-agonists regulate internalization by distinct cytoskeletal pathways","volume":"117","author":"Shumay","year":"2004","journal-title":"J Cell Sci."},{"key":"R109-20230911","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0026-895X(25)08956-4","article-title":"Distinct regulation of beta 1- and beta 2-adrenergic receptors in Chinese hamster fibroblasts","volume":"41","author":"Suzuki","year":"1992","journal-title":"Mol Pharmacol."},{"key":"R110-20230911","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/en.2004-0595","article-title":"The 15-amino acid motif of the C terminus of the beta2-adrenergic receptor is sufficient to confer insulin-stimulated counterregulation to the beta1-adrenergic receptor","volume":"146","author":"Gavi","year":"2005","journal-title":"Endocrinology"},{"key":"R111-20230911","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1210\/en.2006-1569","article-title":"Insulin-like growth factor-I provokes functional antagonism and internalization of beta1-adrenergic receptors","volume":"148","author":"Gavi","year":"2007","journal-title":"Endocrinology"},{"key":"R112-20230911","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/379840a0","article-title":"Insulin action impaired by deficiency of the G-protein subunit G ialpha2","volume":"379","author":"Moxham","year":"1996","journal-title":"Nature"},{"key":"R113-20230911","doi-asserted-by":"crossref","first-page":"34651","DOI":"10.1074\/jbc.M105894200","article-title":"Galpha i2 enhances in vivo activation of and insulin signaling to GLUT4","volume":"276","author":"Song","year":"2001","journal-title":"J Biol Chem."},{"key":"R114-20230911","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s001090050113","article-title":"Conditional, tissue-specific expression of Q205L G alpha i2 in vivo mimics insulin action","volume":"75","author":"Chen","year":"1997","journal-title":"J Mol Med."},{"issue":"pt 3","key":"R115-20230911","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1042\/bj20031659","article-title":"Ligand-dependent autophosphorylation of the insulin receptor is positively regulated by Gi-proteins","volume":"380","author":"Kreuzer","year":"2004","journal-title":"Biochem J."},{"key":"R116-20230911","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0014-5793(93)81518-5","article-title":"Regulation of cardiac insulin receptor function by guanosine nucleotides","volume":"317","author":"Russ","year":"1993","journal-title":"FEBS Lett."},{"key":"R117-20230911","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1042\/bj2700401","article-title":"Insulin receptor function is inhibited by guanosine 5\u2032-[gamma-thio]triphosphate (GTP[S])","volume":"270","author":"Davis","year":"1990","journal-title":"Biochem J."},{"key":"R118-20230911","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/286904a0","article-title":"Insulin trigger, cyclic AMP-dependent activation and phosphorylation of a plasma membrane cyclic AMP phosphodiesterase","volume":"286","author":"Marchmont","year":"1980","journal-title":"Nature"},{"key":"R119-20230911","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0026-895X(25)11115-2","article-title":"Role of hormone-sensitive low Km cAMP phosphodiesterase in regulation of cAMP-dependent protein kinase and lipolysis in rat adipocytes","volume":"35","author":"Smith","year":"1989","journal-title":"Mol Pharmacol."},{"key":"R120-20230911","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbrc.2006.12.141","article-title":"Long-term regulation of cyclic nucleotide phosphodiesterase type 3B and 4 in 3T3-L1 adipocytes","volume":"353","author":"Oknianska","year":"2007","journal-title":"Biochem Biophys Res Commun."},{"key":"R121-20230911","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCULATIONAHA.116.022281","article-title":"Inhibiting insulin-mediated beta2-adrenergic receptor activation prevents diabetes-associated cardiac dysfunction","volume":"135","author":"Wang","year":"2017","journal-title":"Circulation"},{"key":"R122-20230911","first-page":"667","article-title":"Diabetes and hypertension. Nature clinical practice","volume":"3","author":"Lago","year":"2007","journal-title":"Endocrinol Metab."},{"key":"R123-20230911","doi-asserted-by":"crossref","first-page":"12490","DOI":"10.1073\/pnas.93.22.12490","article-title":"Cross-talk between the insulin and angiotensin signaling systems","volume":"93","author":"Velloso","year":"1996","journal-title":"Proc Natl Acad Sci."},{"key":"R124-20230911","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1172\/JCI119752","article-title":"Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin\/angiotensin II crosstalk","volume":"100","author":"Folli","year":"1997","journal-title":"J Clin Invest."},{"key":"R125-20230911","first-page":"1864","article-title":"Serine phosphorylation of insulin receptor substrate-1: a novel target for the reversal of insulin resistance","volume":"15","author":"Sykiotis","year":"2001","journal-title":"Mol Endocrinol."},{"key":"R126-20230911","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1016\/S0021-9258(17)37568-3","article-title":"Serine\/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling","volume":"269","author":"Tanti","year":"1994","journal-title":"J Biol Chem."},{"key":"R127-20230911","doi-asserted-by":"crossref","first-page":"11222","DOI":"10.1074\/jbc.271.19.11222","article-title":"Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action","volume":"271","author":"Mothe","year":"1996","journal-title":"J Biol Chem."},{"key":"R128-20230911","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1210\/en.2004-0466","article-title":"Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems","volume":"146","author":"Calegari","year":"2005","journal-title":"Endocrinology"},{"key":"R129-20230911","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1210\/en.2003-0046","article-title":"Suppressor of cytokine signaling 3 is induced by angiotensin II in heart and isolated cardiomyocytes, and participates in desensitization","volume":"144","author":"Calegari","year":"2003","journal-title":"Endocrinology"},{"key":"R130-20230911","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1677\/joe.0.1810117","article-title":"Angiotensin II (AngII) induces the expression of suppressor of cytokine signaling (SOCS)-3 in rat hypothalamus\u2014a mechanism for desensitization of AngII signaling","volume":"181","author":"Torsoni","year":"2004","journal-title":"J Endocrinol."},{"key":"R131-20230911","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0031-6997(24)01471-6","article-title":"Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells","volume":"52","author":"Touyz","year":"2000","journal-title":"Pharmacol Rev."},{"key":"R132-20230911","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/01.RES.80.1.139","article-title":"Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats","volume":"80","author":"Kudoh","year":"1997","journal-title":"Circ Res."},{"key":"R133-20230911","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/00004872-200109000-00018","article-title":"Endogenous angiotensin II suppresses insulin signaling in vascular smooth muscle cells from spontaneously hypertensive rats","volume":"19","author":"Fukuda","year":"2001","journal-title":"J Hypertens."},{"key":"R134-20230911","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1210\/en.2003-0788","article-title":"The cross-talk between angiotensin and insulin differentially affects phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-mediated signaling in rat heart: implications for insulin resistance","volume":"144","author":"Carvalheira","year":"2003","journal-title":"Endocrinology"},{"key":"R135-20230911","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.mce.2011.12.007","article-title":"Hypothalamic serotonin-insulin signaling cross-talk and alterations in a type 2 diabetic model","volume":"350","author":"Papazoglou","year":"2012","journal-title":"Mol Cell Endocrinol."},{"issue":"suppl 1","key":"R136-20230911","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S0168-8227(11)70019-5","article-title":"Insulin and the heart","volume":"93","author":"Iliadis","year":"2011","journal-title":"Diabetes Res Clin Pract."},{"key":"R137-20230911","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00075198-200310000-00007","article-title":"Insulin: an endogenous cardioprotector","volume":"9","author":"Das","year":"2003","journal-title":"Curr Opin Crit Care."},{"key":"R138-20230911","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bbrc.2015.09.171","article-title":"Insulin\/NFkappaB protects against ischemia-induced necrotic cardiomyocyte death","volume":"467","author":"Diaz","year":"2015","journal-title":"Biochem Biophys Res Commun."},{"key":"R139-20230911","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1067\/mhj.2001.116957","article-title":"Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up","volume":"142","author":"Arnlov","year":"2001","journal-title":"Am Heart J."},{"key":"R140-20230911","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jama.294.3.334","article-title":"Insulin resistance and risk of congestive heart failure","volume":"294","author":"Ingelsson","year":"2005","journal-title":"JAMA"},{"key":"R141-20230911","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.yjmcc.2005.07.017","article-title":"Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary density","volume":"39","author":"McQueen","year":"2005","journal-title":"J Mol Cell Cardiol."},{"key":"R142-20230911","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1172\/JCI40096","article-title":"Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents","volume":"120","author":"Shimizu","year":"2010","journal-title":"J Clin Invest."},{"key":"R143-20230911","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1463-1326.2012.01604.x","article-title":"Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis","volume":"14","author":"Pantalone","year":"2012","journal-title":"Diabetes Obes Metab."},{"key":"R144-20230911","doi-asserted-by":"crossref","first-page":"E1289","DOI":"10.1152\/ajpendo.00373.2007","article-title":"Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride","volume":"293","author":"Basu","year":"2007","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"R145-20230911","first-page":"546","article-title":"Mechanisms of action of GLP-1 in the pancreas","volume":"113","author":"Doyle","year":"2008","journal-title":"Diabetes"},{"key":"R146-20230911","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol Rev."},{"key":"R147-20230911","first-page":"281","article-title":"Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus","volume":"19","author":"Bond","year":"2006","journal-title":"Proc (Bayl Univ Med Cent)."},{"key":"R148-20230911","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11892-007-0056-9","article-title":"GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors","volume":"7","author":"Ahr\u00e9n","year":"2007","journal-title":"Curr Diab Rep."},{"key":"R149-20230911","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1021\/jm070861j","article-title":"Structure-activity and protraction relationship of long-acting glucagon-like peptide-1 derivatives: importance of fatty acid length, polarity, and bulkiness","volume":"50","author":"Madsen","year":"2007","journal-title":"J Med Chem."},{"key":"R150-20230911","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/dmrr.553","article-title":"Structure and function studies of glucagon-like peptide-1 (GLP-1): the designing of a novel pharmacological agent for the treatment of diabetes","volume":"21","author":"Hui","year":"2005","journal-title":"Diabetes Metab Res Rev."},{"key":"R151-20230911","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2147\/VHRM.S1944","article-title":"Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin","volume":"4","author":"Ahren","year":"2008","journal-title":"Vasc Health Risk Manag."},{"key":"R152-20230911","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/dom.12128","article-title":"Combination therapy of dipeptidyl peptidase-4 inhibitors and metformin in type 2 diabetes: rationale and evidence","volume":"16","author":"Liu","year":"2014","journal-title":"Diabetes Obes Metab."},{"key":"R153-20230911","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1185\/030079906X162746","article-title":"Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes","volume":"23","author":"Pratley","year":"2007","journal-title":"Curr Med Res Opin."},{"key":"R154-20230911","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3892\/ijmm.2012.1142","article-title":"GPR40: a therapeutic target for mediating insulin secretion (review)","volume":"30","author":"Feng","year":"2012","journal-title":"Int J Mol Med."},{"issue":"suppl 2","key":"R155-20230911","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.2337\/dcS13-2037","article-title":"Activation of GPR40 as a therapeutic target for the treatment of type 2 diabetes","volume":"36","author":"Burant","year":"2013","journal-title":"Diabetes Care"},{"key":"R156-20230911","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.drudis.2013.09.003","article-title":"Modulating GPR40: therapeutic promise and potential in diabetes","volume":"18","author":"Poitout","year":"2013","journal-title":"Drug Discov Today."},{"key":"R157-20230911","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/jpet.111.183772","article-title":"TAK-875, an orally available G protein-coupled receptor 40\/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats","volume":"339","author":"Tsujihata","year":"2011","journal-title":"J Pharmacol Exp Ther."},{"key":"R158-20230911","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0163-7258(96)00101-5","article-title":"The endothelin system and its potential as a therapeutic target in cardiovascular disease","volume":"72","author":"Gray","year":"1996","journal-title":"Pharmacol Ther."},{"key":"R159-20230911","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF00403325","article-title":"Elevated plasma endothelin in patients with diabetes mellitus","volume":"33","author":"Takahashi","year":"1990","journal-title":"Diabetologia"},{"key":"R160-20230911","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/01.CIR.0000032260.01569.64","article-title":"Increased activity of endogenous endothelin in patients with type II diabetes mellitus","volume":"106","author":"Cardillo","year":"2002","journal-title":"Circulation"},{"key":"R161-20230911","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.lfs.2014.06.008","article-title":"Effects of selective endothelin (ET)-A receptor antagonist versus dual ET-A\/B receptor antagonist on hearts of streptozotocin-treated diabetic rats","volume":"111","author":"Miyauchi","year":"2014","journal-title":"Life Sci."},{"key":"R162-20230911","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000045906","article-title":"Effects of endothelin receptor antagonists on the progression of diabetic nephropathy","volume":"87","author":"Hocher","year":"2001","journal-title":"Nephron"},{"key":"R163-20230911","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/jpet.111.178988","article-title":"Distinct actions of endothelin A-selective versus combined endothelin A\/B receptor antagonists in early diabetic kidney disease","volume":"338","author":"Saleh","year":"2011","journal-title":"J Pharmacol Exp Ther."},{"key":"R164-20230911","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1681\/ASN.2010080869","article-title":"Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy","volume":"22","author":"Kohan","year":"2011","journal-title":"J Am Soc Nephrol."},{"key":"R165-20230911","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2337\/dc11-0064","article-title":"Bromocriptine: a sympatholytic, D2-dopamine agonist for the treatment of type 2 diabetes","volume":"34","author":"DeFronzo","year":"2011","journal-title":"Diabetes Care"},{"key":"R166-20230911","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4093\/dmj.2016.40.2.89","article-title":"Serotonin as a new therapeutic target for diabetes mellitus and obesity","volume":"40","author":"Oh","year":"2016","journal-title":"Diabetes Metab J"},{"key":"R167-20230911","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1440-1681.2006.04410.x","article-title":"5-Hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT)","volume":"33","author":"Ni","year":"2006","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R168-20230911","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nm.3766","article-title":"Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis","volume":"21","author":"Crane","year":"2014","journal-title":"Nat Med."}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005344-201708000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T15:26:21Z","timestamp":1750173981000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005344-201708000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":168,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/fjc.0000000000000481","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}